Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
0.6900
-0.1140 (-14.18%)
At close: Mar 18, 2026, 4:00 PM EDT
0.7500
+0.0600 (8.70%)
After-hours: Mar 18, 2026, 7:39 PM EDT
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $13.21 million as of March 18, 2026. Its market cap has decreased by -81.62% in one year.
Market Cap
13.21M
Enterprise Value
2.87M
1-Year Change
-81.62%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $13.21M, a decrease of -93.67%. That is a compound annual growth rate of -47.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 18.84M | -46.04% |
| Dec 31, 2025 | 34.91M | -56.12% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
| Dec 15, 2021 | 208.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lixte Biotechnology Holdings | 17.17M |
| Intensity Therapeutics | 16.44M |
| Hoth Therapeutics | 16.13M |
| AEON Biopharma | 16.01M |
| Cadrenal Therapeutics | 15.65M |
| Cocrystal Pharma | 15.30M |
| Phio Pharmaceuticals | 14.75M |
| Serina Therapeutics | 14.29M |